U.S. Pharmaceutical Sales - Q3 2013

The following is a list of the top 100 prescribed medicines by US National Sales in Q3 2013. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.

Last updated: February 2014 (updated quarterly).

Top 100 drugs for Q3 2013 by units sold

Rank	Drug	Units (000)
1 (1)	acetaminophen/hydrocodone Generic	9,042	-5.74%	Stats
2 (1)	budesonide Generic	7,998	-21.09%	Stats
3 (1)	ProAir HFA Teva Pharmaceuticals USA, Inc.	7,036	-0.87%	Stats
4 (4)	OneTouch	6,453	7.62%	Stats
5 (1)	Cymbalta	6,160	-7.81%	Stats
6 (1)	Nexium AstraZeneca	5,448	-10.76%	Stats
7 (2)	Advair Diskus GlaxoSmithKline	5,252	-7.01%	Stats
8 (4)	Lantus Solostar Sanofi	4,962	-0.32%	Stats
9 (1)	Lantus Sanofi	4,741	-14.42%	Stats
10 (5)	fentanyl Generic	4,250	11.31%	Stats
11 (2)	enoxaparin Generic	3,827	-10.90%	Stats
12 (2)	Crestor AstraZeneca	3,599	-11.62%	Stats
13 (3)	Spiriva Boehringer Ingelheim Pharmaceuticals, Inc.	3,381	-7.14%	Stats
14 (3)	Levemir Novo Nordisk	3,353	-4.34%	Stats
15 (3)	NovoLog FlexPen Novo Nordisk	2,996	-2.82%	Stats
16 (4)	metoprolol Generic	2,956	-0.50%	Stats
17 ()	Fluzone	2,827	n/a	Stats
18 (3)	Humalog Eli Lilly and Company	2,631	-2.19%	Stats
19	Novolog Novo Nordisk	2,583	-13.18%	Stats
20 (3)	Synthroid AbbVie Inc.	2,401	-7.23%	Stats
21 (3)	Abilify Otsuka Pharmaceutical Co., Ltd	2,359	-5.87%	Stats
22 (3)	Januvia Merck	2,230	-6.26%	Stats
23 (1)	Nasonex Merck	2,135	-19.59%	Stats
24 (3)	Lyrica	2,009	-6.03%	Stats
25 (3)	Zetia Merck	1,953	-1.81%	Stats
26	Symbicort AstraZeneca	1,886	-18.04%	Stats
27 (2)	Namenda Allergan plc	1,875	-4.14%	Stats
28 (2)	Diovan Novartis Pharmaceuticals Corporation	1,724	-8.25%	Stats
29 (2)	Suboxone	1,711	-4.15%	Stats
30 (5)	Remicade Janssen Pharmaceuticals, Inc.	1,648	2.42%	Stats
31 (5)	fenofibrate Generic	1,605	1.13%	Stats
32 (2)	AndroGel AbbVie Inc.	1,591	-2.99%	Stats
33 (1)	Flovent HFA GlaxoSmithKline	1,557	-11.73%	Stats
34 (6)	Dexilant Takeda Pharmaceutical Company Limited	1,453	-2.22%	Stats
35 (3)	Restasis Allergan plc	1,444	-4.75%	Stats
36 (3)	Benicar Daiichi Sankyo	1,413	-5.42%	Stats
37	Lovaza GlaxoSmithKline	1,407	-8.81%	Stats
38 (5)	Lidoderm Endo Pharmaceuticals Inc.	1,373	-18.32%	Stats
39 (2)	Humalog KwikPen Eli Lilly and Company	1,126	-0.88%	Stats
40 (2)	OxyContin Purdue Pharma LP	1,068	-3.52%	Stats
41 (2)	VESIcare Astellas Pharma US, Inc.	1,014	-7.40%	Stats
42 (10)	Xarelto	1,014	21.88%	Stats
43 (2)	Enbrel Amgen Inc.	965	-4.55%	Stats
44 (2)	Vytorin Merck	959	-3.91%	Stats
45 (1)	Celebrex	934	-9.50%	Stats
46 ()	EpiPen 2-Pak	915	n/a	Stats
47 (1)	Janumet Merck	896	-6.08%	Stats
48 (1)	Cialis Eli Lilly and Company	855	-1.61%	Stats
49 ()	Combivent Respimat Boehringer Ingelheim Pharmaceuticals, Inc.	852	n/a	Stats
50 (3)	Pradaxa Boehringer Ingelheim Pharmaceuticals, Inc.	849	-11.19%	Stats
51 (1)	Evista	813	-4.24%	Stats
52 (1)	doxycycline Generic	778	-6.27%	Stats
53 (1)	methylphenidate Generic	718	-7.24%	Stats
54 (1)	Vyvanse Takeda Pharmaceutical Company Limited	713	-5.31%	Stats
55 (1)	amphetamine/dextroamphetamine Generic	702	-5.77%	Stats
56 (5)	Niaspan AbbVie Inc.	677	-18.73%	Stats
57	Humira AbbVie Inc.	659	-4.91%	Stats
58 (1)	Epogen Amgen Inc.	624	2.30%	Stats
59 (1)	Victoza Novo Nordisk	616	-0.65%	Stats
60	Aciphex Eisai Inc.	581	-0.34%	Stats
61	Rituxan Genentech, Inc.	538	-5.78%	Stats
62	Truvada Gilead Sciences, Inc.	535	-4.12%	Stats
63 (1)	Avastin Genentech, Inc.	454	-4.22%	Stats
64 (1)	Rebif EMD Serono, Inc.	452	-14.07%	Stats
65 (2)	modafinil Generic	430	3.37%	Stats
66 (1)	Atripla Gilead Sciences, Inc.	429	-7.74%	Stats
67 (1)	Viagra	402	-7.59%	Stats
68	Seroquel XR AstraZeneca	375	-6.72%	Stats
69 (1)	Renvela Sanofi	336	-0.30%	Stats
70 (2)	Neulasta Amgen Inc.	328	1.55%	Stats
71 (2)	Orencia Bristol-Myers Squibb Company	327	-4.39%	Stats
72 (1)	Sensipar Amgen Inc.	306	-4.08%	Stats
73 (2)	Lunesta Sunovion Pharmaceuticals Inc.	304	-6.17%	Stats
74	Xolair	298	n/a	Stats
75 (1)	Procrit Janssen Pharmaceuticals, Inc.	290	2.47%	Stats
76 ()	Gardasil Merck	287	n/a	Stats
77 (2)	Adderall XR Takeda Pharmaceutical Company Limited	277	-6.73%	Stats
78 (1)	Lucentis Genentech, Inc.	274	2.62%	Stats
79 (2)	Isentress Merck	264	-3.30%	Stats
80 (2)	Prezista Janssen Pharmaceuticals, Inc.	258	-3.37%	Stats
81	Aranesp Amgen Inc.	245	1.66%	Stats
82 (2)	Reyataz Bristol-Myers Squibb Company	237	-9.20%	Stats
83 (1)	Copaxone Teva Pharmaceuticals USA, Inc.	213	-6.58%	Stats
84 (1)	Alimta Eli Lilly and Company	189	-5.50%	Stats
85 (1)	Prevnar 13 Pfizer Inc.	169	3.05%	Stats
86 (2)	Herceptin Genentech, Inc.	162	-2.41%	Stats
87 (2)	Neupogen Amgen Inc.	156	-4.88%	Stats
88 (1)	Invega Sustenna Janssen Pharmaceuticals, Inc.	155	n/a	Stats
89 ()	Zostavax Merck	151	n/a	Stats
90 (1)	Xgeva Amgen Inc.	130	2.36%	Stats
91 (1)	Betaseron Bayer HealthCare Pharmaceuticals Inc.	120	37.93%	Stats
92 ()	Tecfidera Biogen	97	n/a	Stats
93 (2)	Gleevec Novartis Pharmaceuticals Corporation	78	-11.36%	Stats
94 (4)	Avonex Biogen	75	-14.77%	Stats
95	Gilenya Novartis Pharmaceuticals Corporation	61	-1.61%	Stats
96 (2)	Xeloda Genentech, Inc.	59	-6.35%	Stats
97 (1)	Avonex Pen Biogen	48	-7.69%	Stats
98 (1)	Zytiga Janssen Pharmaceuticals, Inc.	34	n/a	Stats
99 (1)	Stelara Janssen Pharmaceuticals, Inc.	27	3.85%	Stats
100 (1)	Afinitor Novartis Pharmaceuticals Corporation	24	n/a	Stats